Indian firms set to launch new drugs in U.S.

05/12/2013 | Business Standard (India)

Despite a lengthy review process by the U.S. FDA, several Gujarat-based pharmaceutical firms are preparing to debut a range of new drugs in the U.S. market in the current fiscal year. Alembic Pharmaceuticals says it has submitted 57 abbreviated new-drug applications and already launched 15 new products. Intas Pharma anticipates introducing about 10 to 15 new drug products in the U.S. in the areas of chronic diseases and oncology.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Matheson Tri-Gas, Inc.
Newark, CA